Apollomics APLM
NASDAQ APLM
$22.28 +1.01 (+4.75%)
At close: Oct 22, 2026 · 4:00 PM EDT

Apollomics (APLM) Preferred Stock Liabilities (2020 - 2022)

Updated

Apollomics' Preferred Stock Liabilities came in at $511.86 million for Q4 2022, up 58.9% from $322.22 million a year earlier.

Analysis

Apollomics (APLM) Preferred Stock Liabilities (2020 - 2022) Analysis & Trends

  • Going back by year, Preferred Stock Liabilities was $322.22 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Apollomics 48.93 Mn 7.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 511.86 Mn
Dec 31, 2021 322.22 Mn
Dec 31, 2020 322.22 Mn
API Access

Apollomics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=APLM&period=max&api_key=YOUR_API_KEY